Connection
Sarah Tevis to Receptor, ErbB-2
This is a "connection" page, showing publications Sarah Tevis has written about Receptor, ErbB-2.
|
|
Connection Strength |
|
 |
|
 |
|
0.185 |
|
|
|
-
Vemuru S, Huang J, Colborn K, Yoon Y, Huynh V, Leonard L, Ahrendt G, Christian N, Afghahi A, McLemore L, Sams S, Tevis S. Clinical implications of receptor conversions in breast cancer patients who have undergone neoadjuvant chemotherapy. Breast Cancer Res Treat. 2023 Jul; 200(2):247-256.
Score: 0.185